Chronic administration of resveratrol prevents morphological changes in prefrontal cortex and hippocampus of aged rats

Neuronal changes after chronic high blood pressure in animal models and its implication for vascular dementia

(2016) Gonzalo Flores et al.   SYNAPSE

The molecular targets of resveratrol

(2015) Sameer S. Kulkarni et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Protection of injured retinal ganglion cell dendrites and unfolded protein response resolution after long-term dietary resveratrol

(2015) James D. Lindsey et al.   NEUROBIOLOGY OF AGING

Resveratrol neuroprotection in stroke and traumatic CNS injury

(2015) Mary S. Lopez et al.   NEUROCHEMISTRY INTERNATIONAL

Dendritic morphology changes in neurons from the ventral hippocampus, amygdala and nucleus accumbens in rats with neonatal lesions into the prefrontal cortex

(2015) Zayda Lazcano et al.   SYNAPSE

Resveratrol Prevents Age-Related Memory and Mood Dysfunction with Increased Hippocampal Neurogenesis and Microvasculature and Reduced Glial Activation

(2015) Maheedhar Kodali et al.   Scientific Reports

Effect of resveratrol on mitochondrial function: Implications in parkin-associated familiar Parkinson's disease

(2014) Anna Ferretta et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Aminoguanidine treatment ameliorates inflammatory responses and memory impairment induced by amyloid-beta 25–35 injection in rats

(2014) Alfonso Díaz et al.   NEUROPEPTIDES

Resveratrol as a Therapeutic Agent for Alzheimer’s Disease

(2014) Teng Ma et al.   Biomed Research International

Resveratrol in Peanuts

(2013) Jocelyn M. Sales et al.   CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION

Design, synthesis and biological evaluation of imine resveratrol derivatives as multi-targeted agents against Alzheimer's disease

(2013) Su-Yi Li et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

Neurodegeneration in Streptozotocin-Induced Diabetic Rats Is Attenuated by Treatment with Resveratrol

(2013) Yu-Hong Jing et al.   NEUROENDOCRINOLOGY

Resveratrol Improves Hippocampal Atrophy in Chronic Fatigue Mice by Enhancing Neurogenesis and Inhibiting Apoptosis of Granular Cells

(2011) Junji Moriya et al.   BIOLOGICAL & PHARMACEUTICAL BULLETIN

Effect of Oral Resveratrol on the BDNF Gene Expression in the Hippocampus of the Rat Brain

(2011) Mostafa Rahvar et al.   NEUROCHEMICAL RESEARCH

Cognitive Performances Are Selectively Enhanced during Chronic Caloric Restriction or Resveratrol Supplementation in a Primate

(2011) Alexandre Dal-Pan et al.   PLoS One

Resveratrol Protects Rats from Aβ-induced Neurotoxicity by the Reduction of iNOS Expression and Lipid Peroxidation

(2011) Tai-Chun Huang et al.   PLoS One

The chronic administration of cerebrolysin induces plastic changes in the prefrontal cortex and dentate gyrus in aged mice

(2011) Ismael Juárez et al.   SYNAPSE

Melatonin Potentiates the Neuroprotective Properties of Resveratrol Against Beta-Amyloid-Induced Neurodegeneration by Modulating AMP-Activated Protein Kinase Pathways

(2010) Kyoung Ja Kwon et al.   Journal of Clinical Neurology

Oral Resveratrol Reduces Neuronal Damage in a Model of Multiple Sclerosis

(2010) Kenneth S Shindler et al.   JOURNAL OF NEURO-OPHTHALMOLOGY

Therapeutic effects of resveratrol during acute periods following experimental ischemic stroke

(2010) Jin A. Shin et al.   JOURNAL OF NEUROIMMUNOLOGY

Antioxidant effects of Epicatechin on the hippocampal toxicity caused by Amyloid-beta 25-35 in rats

(2009) Elvis Cuevas et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Cortico-Basal Ganglia Reward Network: Microcircuitry

(2009) Susan R Sesack et al.   NEUROPSYCHOPHARMACOLOGY

Widespread Changes in Dendritic Spines in a Model of Alzheimer's Disease

(2008) S. Knafo et al.   CEREBRAL CORTEX

Dendritic Spine Loss and Synaptic Alterations in Alzheimer’s Disease

(2008) Marlen Knobloch et al.   MOLECULAR NEUROBIOLOGY

Environmental enrichment reduces the response to stress of the cholinergic system in the prefrontal cortex during aging

(2007) Gregorio Segovia et al.   NEUROCHEMISTRY INTERNATIONAL